AI Revolution Shifts Workforce from Hyper-Specialist to 'Full Stack Builder', LinkedIn's 'Economic Graph' Covers 1.3B Members

ISRO Launches EOS-05: India's First Geo-Imaging Satellite in Geosynchronous Orbit; SC Invokes Article 142 to Quash CJP Protest Cases

A day of high exam relevance: ISRO successfully launched EOS-05, India’s first dedicated geo-imaging satellite in geosynchronous orbit, breaking a failure streak. The Supreme Court used its extraordinary power under Article 142 to close cases linked to CJP protests, raising important constitutional questions. Other key updates include OpenAI’s new autonomous AI model, Manipur’s NRC-first demand for Census deferral, mistrust in GDP data, and Tata Chemicals’ Kenya dispute.

Cabinet Approves Rs 23,731 Cr GOBARdhan Scheme; Rajya Sabha Clears Rs 54,067 Cr Appropriation Bill

The UPSC Key article covers multiple critical topics: the Rajya Sabha cleared the Appropriation Bill for Rs 54,067 Cr excess expenditure, the Cabinet approved the Rs 23,731 Cr GOBARdhan scheme to boost CBG production, and new high-resolution images of the Sun's surface were captured. Also includes data on road safety Good Samaritans, school consolidation, and ethanol policy.

India's R&D Spending, Patents Surge but Systemic Barriers Hinder Science Superpower Status: E-book

A Hindu e-book analyzes India's scientific trajectory, noting increased R&D spending and patent filings but flagging critical gaps: poor lab-to-market translation, bureaucratic hurdles, brain drain, and rising pseudoscience. For exams, this is a rich source of 'Challenges to India's Innovation Ecosystem' for GS3.

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

India Gets First Disease-Modifying Alzheimer's Drug Leqembi After CDSCO Nod

Eisai's Leqembi (lecanemab), India's first disease-modifying therapy for early Alzheimer's, has been launched after CDSCO approval. This marks a shift from symptomatic to disease-modifying treatment, but challenges of early diagnosis, biomarker infrastructure, and affordability remain significant.

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.

$10 Bn AI Investment Can Bring India to AI Frontier in 1 Year: Sarvam AI CEO

India's AI gap with the global frontier is just $10 billion, and with targeted investment, the country can catch up within a year, according to Sarvam AI CEO Pratyush Kumar. The India AI Impact Summit in February saw over $400 billion in AI capex commitments, and voice AI is emerging as India's first billion-dollar revenue opportunity. However, job creation and upskilling remain critical challenges.

TN Budget 2026-27: India's First AI City 'Arivagam' & Space Industrial Zone with ₹35,062 Cr MoUs

Tamil Nadu's TVK-led government, in its maiden Budget for 2026-27, announced India's first AI and innovation city 'Arivagam', a Space Industrial Investment Zone in Thoothukudi and Tirunelveli, and signed MoUs worth ₹35,062 crore that could create 14,790 jobs. This signals a major push for technology and industrial growth in the state.